Search

Author/Creator Gore, Steven D.

3. A phase 2 trial of high dose lenalidomide in patients with relapsed/refractory higher‐risk myelodysplastic syndromes and acute myeloid leukaemia with trilineage dysplasia. (28th October 2016)

Authors:
Zeidan, Amer M.; Smith, B. Douglas; Carraway, Hetty E.; Gojo, Ivana; DeZern, Amy; Gore, Steven D.
Journal:
British journal of haematology
Issue:
Volume 176:Number 2(2017)
Page Start:
241
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Arsenic trioxide during consolidation for patients with previously untreated low/intermediate risk acute promyelocytic leukaemia may eliminate the need for maintenance therapy. (14th February 2014)

Authors:
Coutre, Steven E.; Othus, Megan; Powell, Bayard; Willman, Cheryl L.; Stock, Wendy; Paietta, Elisabeth; Levitan, Denise; Wetzler, Meir; Attar, Eyal C.; Altman, Jessica K.; Gore, Steven D.; Maher, Tracy; Kopecky, Kenneth J.; Tallman, Martin S.; Larson, Richard A.; Appelbaum, Frederick R.
Journal:
British journal of haematology
Issue:
Volume 165:Number 4(2014:May)
Page Start:
497
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Association of provider experience and clinical outcomes in patients with myelodysplastic syndromes receiving hypomethylating agents. Issue 2 (28th January 2020)

Authors:
Zeidan, Amer M.; Hu, Xin; Zhu, Weiwei; Stahl, Maximilian; Wang, Rong; Huntington, Scott F.; Giri, Smith; Bewersdorf, Jan Philipp; Podoltsev, Nikolai A.; Gore, Steven D.; Ma, Xiaomei; Davidoff, Amy J.
Journal:
Leukemia & lymphoma
Issue:
Volume 61:Issue 2(2020)
Page Start:
397
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Azacitidine with or without Entinostat for the treatment of therapy‐related myeloid neoplasm: further results of the E1905 North American Leukemia Intergroup study. (18th November 2015)

Authors:
Prebet, Thomas; Sun, Zhuoxin; Ketterling, Rhett P.; Zeidan, Amer; Greenberg, Peter; Herman, James; Juckett, Mark; Smith, Mitchell R.; Malick, Lisa; Paietta, Elisabeth; Czader, Magdalena; Figueroa, Maria; Gabrilove, Janice; Erba, Harry P.; Tallman, Martin S.; Litzow, Mark; Gore, Steven D.
Journal:
British journal of haematology
Issue:
Volume 172:Number 3(2016)
Page Start:
384
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Beliefs and practice patterns in hyperleukocytosis management in acute myeloid leukemia: a large U.S. web-based survey*. Issue 11 (2nd November 2018)

Authors:
Stahl, Maximilian; Pine, Alexander; Hendrickson, Jeanne E.; Litzow, Mark R.; Luger, Selina M.; Stone, Richard M.; Erba, Harry P.; Kim, Tae Kon; Sekeres, Mikkael A.; Steensma, David P.; Komrokji, Rami S.; Gore, Steven D.; Zeidan, Amer M.
Journal:
Leukemia & lymphoma
Issue:
Volume 59:Issue 11(2018)
Page Start:
2723
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Bone marrow hypocellularity does not affect tolerance or efficacy of azacitidine in patients with higher‐risk myelodysplastic syndromes. (28th January 2014)

Authors:
Seymour, John F.; Bennett, John M.; List, Alan F.; Mufti, Ghulam J.; Gore, Steven D.; Fenaux, Pierre; Santini, Valeria; Hetzer, Joel; Songer, Stephen; Skikne, Barry S.; Beach, Charles L.
Journal:
British journal of haematology
Issue:
Volume 165:Number 1(2014:Apr.)
Page Start:
49
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗